Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |